AT375349B - Verfahren zum herstellen neuer 4-aroylimidazol-2- one und ihrer salze - Google Patents

Verfahren zum herstellen neuer 4-aroylimidazol-2- one und ihrer salze

Info

Publication number
AT375349B
AT375349B AT0314280A AT314280A AT375349B AT 375349 B AT375349 B AT 375349B AT 0314280 A AT0314280 A AT 0314280A AT 314280 A AT314280 A AT 314280A AT 375349 B AT375349 B AT 375349B
Authority
AT
Austria
Prior art keywords
aroylimidazol
salts
producing new
producing
new
Prior art date
Application number
AT0314280A
Other languages
German (de)
English (en)
Other versions
ATA314280A (de
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT375349(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ATA314280A publication Critical patent/ATA314280A/de
Application granted granted Critical
Publication of AT375349B publication Critical patent/AT375349B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0314280A 1979-06-18 1980-06-13 Verfahren zum herstellen neuer 4-aroylimidazol-2- one und ihrer salze AT375349B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
ATA314280A ATA314280A (de) 1983-12-15
AT375349B true AT375349B (de) 1984-07-25

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0314280A AT375349B (de) 1979-06-18 1980-06-13 Verfahren zum herstellen neuer 4-aroylimidazol-2- one und ihrer salze

Country Status (20)

Country Link
AT (1) AT375349B (OSRAM)
AU (1) AU532783B2 (OSRAM)
CA (1) CA1132554A (OSRAM)
CH (1) CH646155A5 (OSRAM)
DE (1) DE3021792A1 (OSRAM)
DK (1) DK160269C (OSRAM)
ES (1) ES492255A0 (OSRAM)
FR (1) FR2459233A1 (OSRAM)
GB (1) GB2055364B (OSRAM)
HK (1) HK61486A (OSRAM)
HU (1) HU186736B (OSRAM)
IE (1) IE50646B1 (OSRAM)
IL (1) IL60243A (OSRAM)
IT (1) IT1143922B (OSRAM)
MY (1) MY8600709A (OSRAM)
NL (2) NL193752C (OSRAM)
NO (1) NO152841C (OSRAM)
NZ (1) NZ193935A (OSRAM)
PH (1) PH18683A (OSRAM)
SE (2) SE447107B (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329470A (en) 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
AU549872B2 (en) * 1981-05-04 1986-02-20 Merrell Dow Pharmaceuticals Inc. 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2560538A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3366698A1 (en) 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NZ193935A (en) 1985-05-31
PH18683A (en) 1985-08-29
SE8501452D0 (sv) 1985-03-25
IT8048997A0 (it) 1980-06-17
ES8105299A1 (es) 1981-06-01
SE464559B (sv) 1991-05-13
NL300015I1 (nl) 2000-11-01
GB2055364B (en) 1983-06-08
CA1132554A (en) 1982-09-28
NO801796L (no) 1980-12-19
AU5911880A (en) 1981-01-08
AU532783B2 (en) 1983-10-13
NO152841B (no) 1985-08-19
MY8600709A (en) 1986-12-31
IL60243A (en) 1987-01-30
SE447107B (sv) 1986-10-27
CH646155A5 (de) 1984-11-15
NO152841C (no) 1985-11-27
IL60243A0 (en) 1980-09-16
DK259080A (da) 1980-12-19
GB2055364A (en) 1981-03-04
FR2459233A1 (fr) 1981-01-09
DE3021792C2 (OSRAM) 1989-08-10
ES492255A0 (es) 1981-06-01
HU186736B (en) 1985-09-30
DK160269C (da) 1991-07-22
DK160269B (da) 1991-02-18
NL193752B (nl) 2000-05-01
SE8501452L (sv) 1985-03-25
SE8004253L (sv) 1980-12-19
HK61486A (en) 1986-08-29
IE801162L (en) 1980-12-18
IE50646B1 (en) 1986-06-11
NL8003498A (nl) 1980-12-22
DE3021792A1 (de) 1981-01-22
NL193752C (nl) 2000-09-04
IT1143922B (it) 1986-10-29
FR2459233B1 (OSRAM) 1983-09-23
NL300015I2 (nl) 2000-10-02
ATA314280A (de) 1983-12-15

Similar Documents

Publication Publication Date Title
AT375349B (de) Verfahren zum herstellen neuer 4-aroylimidazol-2- one und ihrer salze
AT381307B (de) Verfahren zum herstellen neuer carbostyrilderivate und ihrer pharmazeutisch annehmbaren salze
AT376208B (de) Verfahren zum herstellen von neuen piperidinderivaten und deren salzen
AT364363B (de) Verfahren zum herstellen neuer tetrazolylalkoxycarbostyrilderivate
AT367038B (de) Verfahren zum herstellen neuer carbostyrilderivate
AT352736B (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT367418B (de) Verfahren zur herstellung neuer tetrahydropyridinylindolderivate und ihrer salze
AT365181B (de) Verfahren zur herstellung neuer thiazolidinderivate und ihrer salze
AT360013B (de) Verfahren zur herstellung neuer piperidin- derivate und ihrer salze
AT374458B (de) Verfahren zum herstellen von neuen piperidinderivaten und deren salzen
AT376418B (de) Verrahren zum herstellen neuer phenylaethylaminderivate
AT373258B (de) Verfahren zum herstellen von neuen 4-alkyl-8aminoalkyl-psoralenen
AT355565B (de) Verfahren zur herstellung neuer thiazolin- derivate und ihrer salze
ATA863478A (de) Verfahren zur herstellung neuer 1,4-benzodiazepin-derivate und ihrer salze
AT355014B (de) Verfahren zur herstellung neuer 2-benzopyranon- derivate und ihrer salze
AT359491B (de) Verfahren zum herstellen neuer benzamidin- derivate
AT387215B (de) Verfahren zum herstellen neuer carbostyrilderivate und ihrer salze
AT374797B (de) Verfahren zum herstellen neuer phenolester sowie ihren salzen
DD138410A1 (de) Verfahren und einrichtung zum herstellen verschleissfester schneiden
AT369730B (de) Verfahren zum herstellen von neuen basischen p-chloracetophenonoximaethern
AT367045B (de) Verfahren zur herstellung neuer 2-aryl-1hperimidinverbindungen und ihrer salze
ATA263282A (de) Verfahren zur herstellung neuer 2-pyridylaminobenzoes[ure und ihrer salze
ATA8479A (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
ATA554281A (de) Verfahren zur herstellung neuer ergolinderivate und ihrer salze
ATA554181A (de) Verfahren zur herstellung neuer ergolinderivate und ihrer salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time